- Home
- BEEM vs PASG Comparison
BEEM vs PASG Comparison
Compare BEEM & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEEM
- PASG
- Stock Information
- Founded
- BEEM 2006
- PASG 2017
- Country
- BEEM United States
- PASG United States
- Employees
- BEEM N/A
- PASG N/A
- Industry
- BEEM Semiconductors
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- BEEM Technology
- PASG Health Care
- Exchange
- BEEM Nasdaq
- PASG Nasdaq
- Market Cap
- BEEM 31.9M
- PASG 27.6M
- IPO Year
- BEEM N/A
- PASG 2020
- Fundamental
- Price
- BEEM $1.82
- PASG $8.93
- Analyst Decision
- BEEM Strong Buy
- PASG Strong Buy
- Analyst Count
- BEEM 3
- PASG 4
- Target Price
- BEEM $4.00
- PASG $34.50
- AVG Volume (30 Days)
- BEEM 559.8K
- PASG 42.3K
- Earning Date
- BEEM 11-14-2025
- PASG 11-10-2025
- Dividend Yield
- BEEM N/A
- PASG N/A
- EPS Growth
- BEEM N/A
- PASG N/A
- EPS
- BEEM N/A
- PASG N/A
- Revenue
- BEEM $27,668,000.00
- PASG N/A
- Revenue This Year
- BEEM N/A
- PASG N/A
- Revenue Next Year
- BEEM $45.38
- PASG N/A
- P/E Ratio
- BEEM N/A
- PASG N/A
- Revenue Growth
- BEEM N/A
- PASG N/A
- 52 Week Low
- BEEM $1.33
- PASG $5.12
- 52 Week High
- BEEM $4.23
- PASG $26.60
- Technical
- Relative Strength Index (RSI)
- BEEM 34.68
- PASG 55.70
- Support Level
- BEEM $1.64
- PASG $7.13
- Resistance Level
- BEEM $1.76
- PASG $9.12
- Average True Range (ATR)
- BEEM 0.18
- PASG 0.96
- MACD
- BEEM -0.00
- PASG 0.09
- Stochastic Oscillator
- BEEM 24.91
- PASG 66.71
About BEEM Beam Global
Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.